Alcanza Clinical Research, LLC – Trademark Portfolio

Entity Type: 16

Alcanza Clinical Research, LLC holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 23 filings in this category. Currently, 5 trademarks are registered and 17 are pending. Notable registered marks include ALCANZA, CLINICAL RESEARCH FOR ALL, and ALCANZA INCLUSIVE CLINICAL RESEARCH. The owner is based in Lake Mary, FL.

615 Crescent Executive Court

Suite 120

Lake Mary, FL 32746

23 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Alcanza Clinical Research, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (23 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Alcanza Clinical Research, LLC have?

Alcanza Clinical Research, LLC has 23 U.S. trademarks filed with the USPTO. Of these, 5 registered, 17 pending, 1 abandoned.

What trademark classes does Alcanza Clinical Research, LLC file in?

Alcanza Clinical Research, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Alcanza Clinical Research, LLC's most well-known trademarks?

Alcanza Clinical Research, LLC's registered trademark portfolio includes well-known marks such as ALCANZA, CLINICAL RESEARCH FOR ALL, and ALCANZA INCLUSIVE CLINICAL RESEARCH. These are among 5 currently registered trademarks in the portfolio.

What is Alcanza Clinical Research, LLC's trademark registration success rate?

Alcanza Clinical Research, LLC has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 17 applications are pending review.